Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Issam Makhoul
483
•Issam Makhoul•September 8, 2025

Issam Makhoul – FDA 483, Sep 8, 2025

Record Details

An FDA inspection of clinical investigator Issam Makhoul in Little Rock, AR, revealed a significant deviation from the investigational plan. The firm failed to ensure that all subjects met eligibility criteria before randomization into a study. Specifically, subjects using prohibited medications were randomized, compromising the integrity of the clinical trial.

Company
Issam Makhoul
Inspection date
September 8, 2025
Product type
drugs
Office
Dallas District Office
Person
  • Terri E. Gibson
View Company Profile

ID · aedb86ad-a45f-478e-b4a4-94f095af4caa

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Issam Makhoul
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.